FGFR inhibitor AZD4547 can enhance sensitivity of esophageal squamous cell carcinoma cells with epithelial‑mesenchymal transition to gefitinib

Hong Luo(Tongji Hospital), Ge Wang(Army Medical University)
Oncology Reports
March 8, 2018
Cited by 13


Related Papers